Mosquirix (RTS,S/AS01)

RTS,S malaria vaccine with AS01 adjuvant · GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Mosquirix (RTS,S/AS01), covering 2026-01-13 to 2026-01-13. Get the full timeline:

Most recent: Clinical Trial Update: RTSS Vaccine and PBO Net Impact on Malaria Infection and Transmission in Malawi